FDA Approved: TELMISARTAN — Original Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

The FDA approves Jubilant Cadista Pharmaceuticals Inc.'s generic telmisartan (Original Application) for U.S. use as an angiotensin II receptor blocker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

ORIG AP for TELMISARTAN (TELMISARTAN)